AI assistant
ANI PHARMACEUTICALS INC — Director's Dealing 2015
Mar 17, 2015
31676_dirs_2015-03-16_164cc342-5546-4ece-ba0d-b194df5d84e1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2015-03-12
Reporting Person: MARSHBANKS TRACY (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-03-12 | Common Stock | S | 143516 | $63 | Disposed | 375829 | Indirect |
| 2015-03-12 | Common Stock | S | 5978 | $63 | Disposed | 15656 | Indirect |
| 2015-03-12 | Common Stock | S | 58265 | $63 | Disposed | 152579 | Indirect |
| 2015-03-12 | Common Stock | S | 2241 | $63 | Disposed | 5870 | Indirect |
Footnotes
F1: 1: Held by: FA Private Equity Fund IV, L.P., of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).
F2: 2: Held by: FA Private Equity Fund IV GmbH & Co. Beteiligungs KG, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).
F3: 3: Held by: The Productivity Fund IV Liquidating Trust, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).
F4: 4: Held by: The Productivity Fund IV Advisors Fund Liquidating Trust, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).